PREZIOSA, PAOLO
 Distribuzione geografica
Continente #
AS - Asia 4.466
NA - Nord America 2.872
EU - Europa 1.692
SA - Sud America 1.053
AF - Africa 111
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.210
Nazione #
US - Stati Uniti d'America 2.734
SG - Singapore 1.874
CN - Cina 1.173
BR - Brasile 864
HK - Hong Kong 702
IT - Italia 420
SE - Svezia 359
VN - Vietnam 302
DE - Germania 242
RU - Federazione Russa 157
GB - Regno Unito 105
FI - Finlandia 93
IN - India 84
AR - Argentina 76
MX - Messico 65
IR - Iran 59
CA - Canada 56
FR - Francia 50
TR - Turchia 46
NL - Olanda 45
PL - Polonia 45
ZA - Sudafrica 44
AT - Austria 40
ES - Italia 37
JP - Giappone 37
EC - Ecuador 34
BD - Bangladesh 32
SA - Arabia Saudita 26
ID - Indonesia 25
IQ - Iraq 24
EG - Egitto 22
IE - Irlanda 21
VE - Venezuela 19
MA - Marocco 18
CO - Colombia 17
LT - Lituania 17
BE - Belgio 15
PY - Paraguay 15
PT - Portogallo 14
CL - Cile 11
AU - Australia 10
UZ - Uzbekistan 10
PE - Perù 9
PK - Pakistan 9
UA - Ucraina 9
IL - Israele 8
KE - Kenya 8
AE - Emirati Arabi Uniti 7
HN - Honduras 6
KR - Corea 6
AZ - Azerbaigian 5
CH - Svizzera 5
CY - Cipro 5
NG - Nigeria 5
NO - Norvegia 5
TN - Tunisia 5
TW - Taiwan 5
UY - Uruguay 5
CZ - Repubblica Ceca 4
JO - Giordania 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LB - Libano 4
AO - Angola 3
NZ - Nuova Zelanda 3
AL - Albania 2
BO - Bolivia 2
DZ - Algeria 2
EU - Europa 2
MY - Malesia 2
PA - Panama 2
RO - Romania 2
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GI - Gibilterra 1
GT - Guatemala 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
TC - Turks e Caicos 1
TT - Trinidad e Tobago 1
Totale 10.209
Città #
Dallas 960
Singapore 863
Hong Kong 683
Ashburn 349
Hefei 250
Beijing 240
Shanghai 216
Milan 118
Ho Chi Minh City 112
New York 108
Los Angeles 97
Princeton 97
Lawrence 96
Munich 88
São Paulo 87
Boardman 68
Hanoi 65
Moscow 63
Helsinki 56
Nuremberg 45
Rome 40
Mexico City 37
Denver 35
Rio de Janeiro 35
Chennai 34
Warsaw 33
Tokyo 30
Santa Clara 28
Poplar 27
Boston 25
Johannesburg 25
Stockholm 25
Brooklyn 24
Cesano Boscone 24
Orem 23
Houston 22
Ankara 21
Belo Horizonte 21
The Dalles 21
Chicago 20
Dublin 20
Montreal 20
Phoenix 20
Tehran 20
Turku 20
Frankfurt am Main 19
Guangzhou 18
Atlanta 17
Curitiba 17
London 17
Istanbul 16
Manchester 16
Vienna 16
Brasília 15
Lappeenranta 15
Radebeul 15
Shenzhen 15
Da Nang 14
Amsterdam 13
Cairo 13
Washington 13
Haiphong 12
Seattle 12
Tianjin 12
Biên Hòa 11
Brussels 11
Mumbai 11
Toronto 11
Buenos Aires 10
Campinas 10
Charlotte 10
Paris 10
Quito 10
Asunción 9
Erbil 9
Falkenstein 9
Guayaquil 9
New Delhi 9
Porto Alegre 9
Riyadh 9
Assago 8
Baghdad 8
Columbus 8
Dhaka 8
Genoa 8
Guarulhos 8
Hải Dương 8
Palermo 8
Pittsburgh 8
Tashkent 8
Bauru 7
Calgary 7
Hangzhou 7
Jakarta 7
Jeddah 7
Lima 7
Mauá 7
Ninh Bình 7
Pisa 7
Romagnano Sesia 7
Totale 5.903
Nome #
Erratum to: Multiple sclerosis (Nature Reviews Disease Primers, (2018), 4, 1, (43), 10.1038/s41572-018-0041-4) 308
Assessing treatment response to oral drugs for multiple sclerosis in real world setting: a MAGNIMS study 138
Impact of Multiple Sclerosis on Cognitive Aging: A Multicenter Study 137
Dynamic functional connectivity of thalamic sub-regions shows divegent patterns in multiple sclerosis phenotypes 129
Gray matter damage predicts the accumulation of disability 13 years later in MS. 119
A Deep Learning Approach to Predicting Disease Progression in Multiple Sclerosis Using Magnetic Resonance Imaging 118
Voxel-wise multimodal MRI reveals specific patterns of brain damage in the main multiple sclerosis phenotypes 104
Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability 104
Cognitive Reserve Modulates the Impact of Structural Damage of the Frontal Lobe on Executive Functioning in Multiple Sclerosis (P1-1.Virtual) 100
Correspondence among gray matter atrophy and atlas-based neurotransmitter maps is clinically relevant in multiple sclerosis 99
Choroid plexus enlargement in paediatric multiple sclerosis: clinical relevance and effect of sex 86
Functional and structural brain MRI changes associated with cognitive worsening in multiple sclerosis: a 3-year longitudinal study 84
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience 82
Resting State Functional Connectivity Correlates of Executive Function in Patients with Multiple Sclerosis 82
In vivo detection of damage in multiple sclerosis cortex and cortical lesions using NODDI 81
Monoaminergic network abnormalities: a marker for multiple sclerosis-related fatigue and depression 76
Advanced diffusion-weighted imaging models better characterize white matter neurodegeneration and clinical outcomes in multiple sclerosis 75
Tolebrutinib for non-relapsing secondary progressive multiple sclerosis: a critical therapeutic gap 74
Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial 74
Resting state functional connectivity modifications in monoaminergic circuits underpin fatigue development in patients with multiple sclerosis 71
Unraveling the heterogeneous pathological substrates of relapse-onset multiple sclerosis: a multiparametric voxel-wise 3 T MRI study 69
A semiautomatic method for multiple sclerosis lesion segmentation on dual-echo MR imaging: application in a multicenter context 68
Functional and structural MRI correlates of executive functions in multiple sclerosis 66
In vivo quantification of brain soma and neurite density abnormalities in multiple sclerosis 65
Sex hormone-related factors and the risk of PIRA in women with multiple sclerosis 64
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response 64
Association between pathological and MRI findings in multiple sclerosis 63
Regional white matter and gray matter damage and cognitive performances in multiple sclerosis according to sex 62
Action observation training modifies brain gray matter structure in healthy adult individuals 62
Diagnosis of Progressive Multiple Sclerosis from the Imaging Perspective: A Review 62
Atrioventricular block after fingolimod resumption: a consequence of sphingosine-1-phosphate axis alteration due to COVID-19? 62
Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study 62
Association of Gray Matter Atrophy Patterns with Clinical Phenotype and Progression in Multiple Sclerosis 60
Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis 59
Clinical Relevance of Multiparametric MRI Assessment of Cervical Cord Damage in Multiple Sclerosis 59
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives 59
Machine learning-driven diagnosis of multiple sclerosis from whole blood transcriptomics 58
Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series 58
Dynamics of choroid plexus volume is associated with the presence and development of fatigue in multiple sclerosis 58
Cross-modal plasticity among sensory networks in neuromyelitis optica spectrum disorders 58
Application of advanced MRI techniques to monitor pharmacologic and rehabilitative treatment in multiple sclerosis: current status and future perspectives 58
Amyloid-β, p-tau and reactive microglia are pathological correlates of MRI cortical atrophy in Alzheimer's disease 58
Cerebrospinal Fluid-In Gradient of Cortical and Deep Gray Matter Damage in Multiple Sclerosis 57
What role should spinal cord MRI take in the future of multiple sclerosis surveillance? 57
Action observation training promotes motor improvement and modulates functional network dynamic connectivity in multiple sclerosis 57
Advances in neuroimaging of multiple sclerosis 56
Spatial correspondence among regional gene expressions and gray matter volume loss in multiple sclerosis 55
Assessing treatment response to oral drugs for multiple sclerosis in real world setting: a MAGNIMS study 55
Brain and cervical spinal cord MRI correlates of sensorimotor impairment in patients with multiple sclerosis 54
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis 54
Cognitive Impairment Is Related to Glymphatic System Dysfunction in Pediatric Multiple Sclerosis 54
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis? 54
Chronic Active Lesions and Larger Choroid Plexus Explain Cognition and Fatigue in Multiple Sclerosis 53
Choroid plexus and perivascular space enlargement in neuropsychiatric systemic lupus erythematosus 53
Structural and functional magnetic resonance imaging correlates of fatigue and dual-task performance in progressive multiple sclerosis 52
Neuromyelitis optica spectrum disorder and multiple sclerosis in a Sardinian family 52
Pediatric multiple sclerosis: developments in timely diagnosis and prognostication 52
Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study 51
Axonal degeneration as substrate of fractional anisotropy abnormalities in multiple sclerosis cortex 51
Cortical axonal loss is associated with both gray matter demyelination and white matter tract pathology in progressive multiple sclerosis: Evidence from a combined MRI-histopathology study 51
Exploring the Association of HLA Genetic Risk Burden on Thalamic and Hippocampal Atrophy in Multiple Sclerosis Patients 50
The insula modulates the effects of aerobic training on cardiovascular function and ambulation in multiple sclerosis 50
Diagnostic Criteria for Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Myelin Oligodendrocyte Glycoprotein–immunoglobulin G-associated Disease 50
A demyelinating disorder characterized by repeated episodes of optic neuritis and brainstem dysfuntions in a girl with anti-MOG positivity 50
Intrinsic damage to the major white matter tracts in patients with different clinical phenotypes of multiple sclerosis: a voxelwise diffusion-tensor MR Study 50
Neurite density explains cortical T1-weighted/T2-weighted ratio in multiple sclerosis 50
Central vein sign and iron rim in multiple sclerosis: ready for clinical use? 50
Clinically isolated syndromes suggestive of multiple sclerosis: dynamic patterns of gray and white matter changes - a 2 year MR imaging study 50
Divergent time-varying connectivity of thalamic sub-regions characterizes clinical phenotypes and cognitive status in multiple sclerosis 50
Clinical relevance of spatial correspondence between regional gene expression and grey matter atrophy in multiple sclerosis 49
Application of DIR and DT MRI to quantify focal and diffuse cortical damage in MS. 49
MRI of Transcallosal White Matter Helps to Predict Motor Impairment in Multiple Sclerosis 49
Sex-related differences in upper limb motor function in healthy subjects and multiple sclerosis patients: a multiparametric MRI study 49
Subventricular Zone Microstructure in Pediatric-Onset Multiple Sclerosis 49
Human functional MRI 47
Brain mapping in multiple sclerosis: Lessons learned about the human brain 47
Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines 47
Occurrence and microstructural features of slowly expanding lesions on fingolimod or natalizumab treatment in multiple sclerosis 47
Cervical spinal cord gray matter damage predicts disability worsening in multiple sclerosis: a longitudinal study 46
Wallerian and trans-synaptic degeneration contribute to optic radiation damage in multiple sclerosis: a diffusion tensor MRI study 46
Effects of Natalizumab and Fingolimod on Clinical, Cognitive, and Magnetic Resonance Imaging Measures in Multiple Sclerosis 46
Resting state network functional connectivity abnormalities in systemic lupus erythematosus: correlations with neuropsychiatric impairment 46
Quantitative MRI adds to neuropsychiatric lupus diagnostics 46
Can post-mortem MRI be used as a proxy for in vivo? A case study 45
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study 45
Different CSF-in gradients of damage occur in the thalamus, caudate nucleus and cortex in multiple sclerosis: a 3T magnetization transfer ratio and R2*study 44
Brain reserve against physical disability progression over five years in multiple sclerosis 44
Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis 43
Choroid plexus and perivascular spaces enlargement in neuropsychiatric systemic lupus erythematosus 43
Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective 43
Current state-of-art of the application of serum neurofilaments in multiple sclerosis diagnosis and monitoring 43
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis 42
Age Matters in Multiple Sclerosis: Novel Insights Into Disease Progression From Clinical Onset 42
Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis 42
The current role of MRI in differentiating multiple sclerosis from its imaging mimics 42
Paramagnetic rim and core sign lesions in paediatric multiple sclerosis patients 41
Correction to: Moving towards a new era for the treatment of neuromyelitis optica spectrum disorders (Journal of Neurology, (2024), 271, 7, (3879-3896), 10.1007/s00415-024-12426-w) 41
Cognitive impairment in benign multiple sclerosis: a multiparametric structural and functional MRI study 41
Identifying Progression in Multiple Sclerosis: New Perspectives 41
Erratum: The current role of MRI in differentiating multiple sclerosis from its imaging mimics (Nature reviews. Neurology (2018)) 41
Totale 6.299
Categoria #
all - tutte 64.442
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.442


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 0 16 4 1 7 2 5 1
2021/2022130 1 4 5 40 2 10 11 19 15 7 9 7
2022/2023737 225 116 57 8 21 79 25 42 66 31 20 47
2023/2024725 32 46 52 111 65 81 59 68 9 53 49 100
2024/20253.468 250 97 102 85 124 183 256 357 688 568 287 471
2025/20265.564 914 948 1.052 1.608 839 203 0 0 0 0 0 0
Totale 10.733